Global Computational Biology Market Overview:
Global Computational Biology Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Computational Biology Market Report 2025 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Computational Biology involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Computational Biology Market:
The Computational Biology Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Computational Biology Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Computational Biology Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Computational Biology market has been segmented into:
Contract Services
In-House Services
By Application, Computational Biology market has been segmented into:
Drug Discovery & Disease Modelling
Cellular & Biological Simulation
Clinical Trials
Preclinical Drug Development
Human Body Simulation Software
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Computational Biology market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Computational Biology market.
Top Key Players Covered in Computational Biology market are:
Certara LP
Chemical Computing Group ULC
Compugen Ltd.
Dassault Systemes
Genedata AG
Insilico Biotechnology AG
Leadscope Inc.
Nimbus Therapeutics
Rosa & Co. LLC
Schrodinger LLC
Simulations Plus Inc.
Strand Life Sciences Pvt. Ltd.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Computational Biology Market Type
4.1 Computational Biology Market Snapshot and Growth Engine
4.2 Computational Biology Market Overview
4.3 Contract Services
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Contract Services: Geographic Segmentation Analysis
4.4 In-House Services
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 In-House Services: Geographic Segmentation Analysis
Chapter 5: Computational Biology Market Application
5.1 Computational Biology Market Snapshot and Growth Engine
5.2 Computational Biology Market Overview
5.3 Drug Discovery & Disease Modelling
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Drug Discovery & Disease Modelling: Geographic Segmentation Analysis
5.4 Cellular & Biological Simulation
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Cellular & Biological Simulation: Geographic Segmentation Analysis
5.5 Clinical Trials
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Clinical Trials: Geographic Segmentation Analysis
5.6 Preclinical Drug Development
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Preclinical Drug Development: Geographic Segmentation Analysis
5.7 Human Body Simulation Software
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Human Body Simulation Software: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Computational Biology Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 CERTARA LP; CHEMICAL COMPUTING GROUP ULC; COMPUGEN LTD.; DASSAULT SYSTEMES; GENEDATA AG; INSILICO BIOTECHNOLOGY AG; LEADSCOPE
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; NIMBUS THERAPEUTICS; ROSA & CO. LLC; SCHRODINGER LLC; SIMULATIONS PLUS
6.4 INC.; STRAND LIFE SCIENCES PVT.
6.5 LTD.
Chapter 7: Global Computational Biology Market By Region
7.1 Overview
7.2. North America Computational Biology Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Contract Services
7.2.2.2 In-House Services
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Drug Discovery & Disease Modelling
7.2.3.2 Cellular & Biological Simulation
7.2.3.3 Clinical Trials
7.2.3.4 Preclinical Drug Development
7.2.3.5 Human Body Simulation Software
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Computational Biology Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Contract Services
7.3.2.2 In-House Services
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Drug Discovery & Disease Modelling
7.3.3.2 Cellular & Biological Simulation
7.3.3.3 Clinical Trials
7.3.3.4 Preclinical Drug Development
7.3.3.5 Human Body Simulation Software
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Computational Biology Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Contract Services
7.4.2.2 In-House Services
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Drug Discovery & Disease Modelling
7.4.3.2 Cellular & Biological Simulation
7.4.3.3 Clinical Trials
7.4.3.4 Preclinical Drug Development
7.4.3.5 Human Body Simulation Software
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Computational Biology Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Contract Services
7.5.2.2 In-House Services
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Drug Discovery & Disease Modelling
7.5.3.2 Cellular & Biological Simulation
7.5.3.3 Clinical Trials
7.5.3.4 Preclinical Drug Development
7.5.3.5 Human Body Simulation Software
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Computational Biology Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Contract Services
7.6.2.2 In-House Services
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Drug Discovery & Disease Modelling
7.6.3.2 Cellular & Biological Simulation
7.6.3.3 Clinical Trials
7.6.3.4 Preclinical Drug Development
7.6.3.5 Human Body Simulation Software
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Computational Biology Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Contract Services
7.7.2.2 In-House Services
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Drug Discovery & Disease Modelling
7.7.3.2 Cellular & Biological Simulation
7.7.3.3 Clinical Trials
7.7.3.4 Preclinical Drug Development
7.7.3.5 Human Body Simulation Software
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Computational Biology Scope:
|
Report Data
|
Computational Biology Market
|
|
Computational Biology Market Size in 2025
|
USD XX million
|
|
Computational Biology CAGR 2025 - 2032
|
XX%
|
|
Computational Biology Base Year
|
2024
|
|
Computational Biology Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Certara LP, Chemical Computing Group ULC, Compugen Ltd., Dassault Systemes, Genedata AG, Insilico Biotechnology AG, Leadscope Inc., Nimbus Therapeutics, Rosa & Co. LLC, Schrodinger LLC, Simulations Plus Inc., Strand Life Sciences Pvt. Ltd..
|
|
Key Segments
|
By Type
Contract Services
In-House Services
By Applications
Drug Discovery & Disease Modelling
Cellular & Biological Simulation
Clinical Trials
Preclinical Drug Development
Human Body Simulation Software
|
